Immunic AG | Finanzwire

BRIEF

published on 04/30/2026 at 12:35, 1 day 11 hours ago

Immunic to Attend Key Conferences in May

Vidofludimus Calcium Multiple Sclerosis Research Immunic Conferences Bio€quity Europe Biotechnology News
PRESS RELEASE

published on 04/30/2026 at 12:30, 1 day 11 hours ago

Immunic to Participate in Investor and Medical Conferences in May
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and medical conferences in May to present innovative therapies for neurologic diseases

Investor Conferences Immunic Medical Conferences Novel Therapies Neurologic Diseases
BRIEF

published on 04/28/2026 at 12:35, 3 days 11 hours ago

Immunic Appoints Michael A. Panzara as Chief Medical Officer

Chief Medical Officer Immunic Inc. Vidofludimus Calcium Michael A. Panzara Neurology Drug Development
PRESS RELEASE

published on 04/28/2026 at 12:30, 3 days 11 hours ago

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity

Chief Medical Officer Immunic Neurology Commercial-stage Michael A. Panzara
BRIEF

published on 04/23/2026 at 14:05, 8 days 9 hours ago

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Reverse Stock Split Immunic Inc. Stockholder Meeting Share Reduction Nasdaq IMUX
PRESS RELEASE

published on 04/23/2026 at 14:00, 8 days 9 hours ago

Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Immunic, Inc. announces a 1-for-10 reverse stock split to meet contractual obligations, reducing outstanding shares from 136M to 13.6M

Shareholders Reverse Stock Split Nasdaq Immunic Inc. Neurologic Diseases
BRIEF

published on 04/09/2026 at 12:35, 22 days 11 hours ago

Immunic to Engage in Key Scientific Conferences in April

Biotechnology Clinical Trials Conférences Oral Therapies Neurology
PRESS RELEASE

published on 04/09/2026 at 12:30, 22 days 11 hours ago

Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF

published on 04/01/2026 at 12:35, 1 month ago

Immunic Achieves Nasdaq Compliance

Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
PRESS RELEASE

published on 04/01/2026 at 12:30, 1 month ago

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days

Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases

Published on 05/01/2026 at 22:30, 1 hour 25 minutes ago

Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 1 hour 25 minutes ago

Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing
Published on 05/01/2026 at 22:30, 1 hour 25 minutes ago

Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.
Published on 05/01/2026 at 18:00, 5 hours 55 minutes ago

Star Copper to Present at the Emerging Growth Conference on May 7, 2026
Published on 05/01/2026 at 15:35, 8 hours 20 minutes ago

LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 4 hours 32 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 5 hours 15 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 6 hours 8 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 6 hours 10 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 6 hours 34 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 3 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 4 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 4 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 5 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 5 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News